Literature DB >> 26400224

Downregulation of MicroRNA-152 contributes to high expression of DKK1 in multiple myeloma.

Yinyin Xu1,2, Bingda Chen3,2, Suraj K George4, Beizhong Liu1.   

Abstract

Multiple myeloma (MM) induced bone lesion is one of the most crippling characteristics, and the MM secreted Dickkopf-1 (DKK1) has been reported to play important role in this pathologic process. However, the underlying regulation mechanisms involved in DKK1 expression are still unclear. In this study, we validated the expression patterns of microRNA (miR) 15a, 34a, 152, and 223 in MM cells and identified that miR-152 was significantly downregulated in the MM group compared with the non-MM group, and that miR-152 level was negatively correlated with the expression of DKK1 in the MM cells. Mechanistic studies showed that manipulating miR-152 artificially in MM cells led to changes in DKK-1 expression, and miR-152 blocked DKK1 transcriptional activity by binding to the 3'UTR of DKK1 mRNA. Importantly, we revealed that MM cells stably expressing miR-152 improved the chemotherapy sensitivity, and counteracted the bone disruption in an intrabone-MM mouse model. Our study contributes better understanding of the regulation mechanism of DKK-1 in MM, and opens up the potential for developing newer therapeutic strategies in the MM treatment.

Entities:  

Keywords:  bone disruption; dickkopf homolog 1; microRNA152; multiple myeloma

Mesh:

Substances:

Year:  2015        PMID: 26400224      PMCID: PMC4833491          DOI: 10.1080/15476286.2015.1094600

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  53 in total

1.  MicroRNAs, macrocontrol: regulation of miRNA processing.

Authors:  Izabella Slezak-Prochazka; Selvi Durmus; Bart-Jan Kroesen; Anke van den Berg
Journal:  RNA       Date:  2010-04-27       Impact factor: 4.942

2.  A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma.

Authors:  William G Gunn; Adam Conley; Lisa Deininger; Scott D Olson; Darwin J Prockop; Carl A Gregory
Journal:  Stem Cells       Date:  2005-11-17       Impact factor: 6.277

Review 3.  MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.

Authors:  K Musilova; M Mraz
Journal:  Leukemia       Date:  2014-12-26       Impact factor: 11.528

4.  A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study.

Authors:  Sagar Lonial; Jonathan Kaufman; Mourad Tighiouart; Ajay Nooka; Amelia A Langston; Leonard T Heffner; Claire Torre; Stephanie McMillan; Heather Renfroe; R Donald Harvey; Mary J Lechowicz; H Jean Khoury; Christopher R Flowers; Edmund K Waller
Journal:  Clin Cancer Res       Date:  2010-08-25       Impact factor: 12.531

Review 5.  MicroRNA theragnostics for the clinical management of multiple myeloma.

Authors:  N Ahmad; S Haider; S Jagannathan; E Anaissie; J J Driscoll
Journal:  Leukemia       Date:  2013-09-12       Impact factor: 11.528

6.  Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.

Authors:  Ya-Wei Qiang; Bart Barlogie; Stuart Rudikoff; John D Shaughnessy
Journal:  Bone       Date:  2007-12-27       Impact factor: 4.398

7.  Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis.

Authors:  Yuhuan Zheng; Zhen Cai; Siqing Wang; Xiang Zhang; Jianfei Qian; Sungyoul Hong; Haiyan Li; Michael Wang; Jing Yang; Qing Yi
Journal:  Blood       Date:  2009-08-26       Impact factor: 22.113

8.  Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.

Authors:  Suraj Konnath George; Veronica Tovar-Sepulveda; Steven S Shen; Weiguo Jian; Yiqun Zhang; Susan G Hilsenbeck; Seth P Lerner; Carolyn L Smith
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

Review 9.  The microRNA-148/152 family: multi-faceted players.

Authors:  Yue Chen; Yong-Xi Song; Zhen-Ning Wang
Journal:  Mol Cancer       Date:  2013-05-19       Impact factor: 27.401

Review 10.  MicroRNA: important player in the pathobiology of multiple myeloma.

Authors:  Chonglei Bi; Wee Joo Chng
Journal:  Biomed Res Int       Date:  2014-06-03       Impact factor: 3.411

View more
  11 in total

1.  Long Noncoding RNA H19 Promotes Tumorigenesis of Multiple Myeloma by Activating BRD4 Signaling by Targeting MicroRNA 152-3p.

Authors:  Ji-Fu Zheng; Ning-Hong Guo; Fu-Ming Zi; Jing Cheng
Journal:  Mol Cell Biol       Date:  2020-01-16       Impact factor: 4.272

2.  Evaluation of the cargo contents and potential role of extracellular vesicles in osteoporosis.

Authors:  Jifeng Xu; Yu Chen; Dongsheng Yu; Li Zhang; Xiaofan Dou; Gang Wu; Yaping Wang; Shuijun Zhang
Journal:  Aging (Albany NY)       Date:  2021-08-10       Impact factor: 5.682

3.  Membrane-bound Dickkopf-1 in Foxp3+ regulatory T cells suppresses T-cell-mediated autoimmune colitis.

Authors:  Wook-Jin Chae; Jong-Hyun Park; Octavian Henegariu; Saliha Yilmaz; Liming Hao; Alfred L M Bothwell
Journal:  Immunology       Date:  2017-06-27       Impact factor: 7.397

Review 4.  New agents in the Treatment of Myeloma Bone Disease.

Authors:  Elizabeth S Ring; Michelle A Lawson; John A Snowden; Ingrid Jolley; Andrew D Chantry
Journal:  Calcif Tissue Int       Date:  2017-11-02       Impact factor: 4.333

Review 5.  New Insights Into Monogenic Causes of Osteoporosis.

Authors:  Riikka E Mäkitie; Alice Costantini; Anders Kämpe; Jessica J Alm; Outi Mäkitie
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-25       Impact factor: 5.555

6.  MicroRNA-152 Inhibits Cell Proliferation, Migration, and Invasion in Breast Cancer.

Authors:  Adilijiang Maimaitiming; Ailijiang Wusiman; Abulajiang Aimudula; Xuekelaiti Kuerban; Pengcheng Su
Journal:  Oncol Res       Date:  2019-04-08       Impact factor: 5.574

7.  The Biological Effects of Dickkopf1 on Small Cell Lung Cancer Cells and Bone Metastasis.

Authors:  Hailin Pang; Ningqiang Ma; Mi Jiao; Weiwei Shen; Bo Xin; Tongfei Wang; Feng Zhang; Lili Liu; Helong Zhang
Journal:  Oncol Res       Date:  2017-01-02       Impact factor: 5.574

Review 8.  Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy.

Authors:  Dimitri Papukashvili; Nino Rcheulishvili; Cong Liu; Fengfei Xie; Deependra Tyagi; Yunjiao He; Peng George Wang
Journal:  Cells       Date:  2021-10-30       Impact factor: 6.600

9.  The role of Wnt signaling pathway in atherosclerosis and its relationship with angiogenesis.

Authors:  Jingru Du; Junfeng Li
Journal:  Exp Ther Med       Date:  2018-07-03       Impact factor: 2.447

Review 10.  Roles of miRNA dysregulation in the pathogenesis of multiple myeloma.

Authors:  Dan Chen; Xinhong Yang; Min Liu; Zhihua Zhang; Enhong Xing
Journal:  Cancer Gene Ther       Date:  2021-01-05       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.